ANAVEX LIFE SCIENCES CORP. company info

CIK 1314052
IRS Number 208365999
State of incorporation NV
Business address 51 W 52ND STREET,
7TH FLOOR
NEW YORK
NY
10019-6163
Mail address 51 W 52ND STREET,
7TH FLOOR
NEW YORK
NY
10019-6163

Short summary

ANAVEX LIFE SCIENCES CORP. is a New York company, with head office located at 51 W 52Nd Street, New York, New York 10019-6163. In 2018 the company owned a total of 20.55 million USD worth of assets, including 20.55 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

ANAVEX LIFE SCIENCES CORP. Income Statement

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Research and development 2.732.602.650.260.732.277.2510.6713.34
Operating Expenses 2.977.1115.5915.6819.33
Operating Income (Loss) -5.65-6.18-4.32-2.14-2.97
Interest expense 0.280.090.140.050.010.07
Income Tax Expense (Benefit) -1.40
Net income -0.01-0.09-0.03-1.58-5.35-5.50-8.78-7.31-8.30-3.70-11.37-12.11-14.74-13.46-17.45

ANAVEX LIFE SCIENCES CORP. Balance Sheet

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 24.7925.8319.46
Total assets 1.280.020.009.317.989.8424.9126.7920.55
Current assets 1.280.020.008.207.989.8424.8526.7420.55
Total current liabilities 2.891.901.352.171.453.216.37
Long-term Debt, Excluding Current Maturities 5.720.00
Long-term Debt 5.720.00
Total liabilities 2.252.223.561.911.412.173.193.58
Common Stock, Value, Issued 0.030.030.030.040.090.040.040.050.05
Retained Earnings (Accumulated Deficit) -51.17-71.51-86.32-103.14-124.27

ANAVEX LIFE SCIENCES CORP. Cash Flow

Name [in Millions USD]200420052006200720082009201020112012201320142015201620172018Trends
Net income -0.01-0.09-0.03-1.58-5.35-5.50-8.78-7.31-8.30-3.70-11.37-12.11-14.74-13.46-17.45
Depreciation and amortization 0.000.000.000.000.00
Depreciation and amortization 0.000.000.00
Deferred Income Tax Expense (Benefit) -1.40
Accounts receivable 0.080.00-0.050.03
Net Cash Provided by (Used in) Operating Activities -4.59-3.80-1.69-0.78-2.66-4.23-9.24-9.02-12.58
Payments to Acquire Property, Plant, and Equipment 0.00
Net Cash Provided by (Used in) Investing Activities -0.00000-0.00
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.00
Proceeds from Issuance of Common Stock 3.103.021.000.800.3712.343.1727.278.17
Net Cash Provided by (Used in) Financing Activities 4.513.671.571.119.5812.263.1327.278.07
Cash and Cash Equivalents, Period Increase (Decrease) -0.09-0.13-0.120.336.92